Showing results (2031-2040 of 2,545) with videos related to

Sort By:
Pageof 255
The Journal of Clinical Endocrinology and Metabolism|October 5, 2021
Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 DiabetesValentina Pirro, Kenneth D Roth, Yanzhu Lin, et al.
The Lancet. Diabetes & Endocrinology|April 25, 2022
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trialTim Heise, Andrea Mari, J Hans DeVries, et al.
Nutrients|March 12, 2022
The Impact of a High-Carbohydrate/Low Fat vs. Low-Carbohydrate Diet on Performance and Body Composition in Physically Active Adults: A Cross-Over Controlled TrialNadine B Wachsmuth, Felix Aberer, Sandra Haupt, et al.
Plos One|May 16, 2020
The influenza replication blocking inhibitor LASAG does not sensitize human epithelial cells for bacterial infectionsJanine J Wilden, Andre van Krüchten, Lutz Gieselmann, et al.
Vaccine|May 18, 2020
Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaquesEric Dumonteil, Claudia Herrera, Weihong Tu, et al.
Diabetes Care|April 16, 2020
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 DiabetesMark L Hartman, Arun J Sanyal, Rohit Loomba, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 31, 2008
Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for NeuroblastomaAndrea Di Cataldo, Daniela Dau, Massimo Conte, et al.
OTO Open|June 12, 2024
Associations Between Race and Survival Outcomes Among Veterans With Head and Neck Cancer in a Racially Diverse SettingAmanda R Walsh, Jonathan P Giurintano, Jessica H Maxwell, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 11, 2023
Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosisTim Moderer, Ioana Puşcalău-Gîrţu, Christian Haupt, et al.
Diabetes, Obesity & Metabolism|September 20, 2021
The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysisJonathan M Wilson, Yanzhu Lin, M Jane Luo, et al.
Pageof 255